HDAC Inhibitors in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled proliferation, differentiation arrest, and accumulation of immature myeloid progenitors. Although clinical advances in AML have been made, especially in young patients, long-term disease-free survival remains po...

Descripción completa

Detalles Bibliográficos
Autores principales: San José-Enériz, Edurne, Gimenez-Camino, Naroa, Agirre, Xabier, Prosper, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896008/
https://www.ncbi.nlm.nih.gov/pubmed/31739588
http://dx.doi.org/10.3390/cancers11111794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896008/
https://www.ncbi.nlm.nih.gov/pubmed/31739588
http://dx.doi.org/10.3390/cancers11111794

Ejemplares similares